onda

News

  • The EuroHPC Joint Undertaking in action: the first steps to acquiring world-class supercomputers

    On 15 February, the European High Performance Computing Joint Undertaking (EuroHPC JU) launched its first Calls for Expression of Interest to select the sites that will host its first supercomputers Joint Undertaking by the end of 2020.
    -Read more-
  • Horizon Europe Programme negotiations update

    The first evaluation of Future and Emerging Technologies (FET) Innovation Launchpad actions under the European Innovation Council (EIC) pilot selected 25 proposals, which will receive an invitation for grant agreement preparation.
    -Read more-
  • EU-India collaboration on STriTuVaD project to tackle tuberculosis in India

    On 4 February, the European External Action Service – the European Union’s diplomatic service – published an article on the EU-India cooperation on health and the EU co-funded project – In Silico Trial for Tuberculosis Vaccine (StriTuVaD).
    -Read more-
  • In silico method mentioned in JRC report on alternatives to animal testing

    On 7 February, the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) published a status report on alternatives to animal testing.
    -Read more-
  • FDA Commissioner Gottlieb resigns

    Our President, Prof Marco Viceconti, shares his view on the recent resignation of the Food and Drug Administration Commissioner Scott Gottlieb, a supporter of in silico medicine.
    -Read more-
  • A virtual patient to conduct clinical trials in asthma

    Himanshu Kaul, our member from University of Toronto, reports the study of a new drug that reduces airway muscle mass in severe asthmatics. The strength of this work is the integration of findings from in vivo clinical trials and in vitro and computational models, demonstrating the key role of in silico clinical trials in the design of new drugs.
    -Read more-

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Accept Privacy Policy

ARCHIVE

Read all the newsletters of the VPH Institute

GO